Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #74675 on US Stem Cell Inc (USRM)
NoMoDo
07/26/17 11:12 AM
#74678 RE: Ryguy008 #74675
It's just all the money that was in this was due to RMAT speculation.
I see the following as the reasons the stock has seen such gains and the reason I own shares in the company: 1. Toxic debt removed 2. Lawsuit from Nothrstar that could have bankrupted company settled 3. Addition of a seasoned professional on the BOD 4. Agreement with GACP to fund 10 new clinics with $500k upfront cash. 5. GACP agrees to fund Marketing costs for next 3 years (largest drain on revenues) 6. 50% increase in revenues to $3 mil in 2016 7. First time ever with positive cash on hand 8. Insider buying This all happened within the last month and was timed with the rise in sp. I don't believe that FDA designation has been priced in yet because we sit on the pinks. The stock is worth over a buck with just the above.